Role of transforming growth factor beta in cancer (Q34136011)

31 July 2017

1 reference

title

Role of transforming growth factor beta in cancer (English)

1 reference

31 July 2017

Pasche B

1

1 reference

31 July 2017

1 February 2001

1 reference

Journal of Cellular Physiology

31 July 2017

1 reference

31 July 2017

186

1 reference

31 July 2017

153-168

1 reference

31 July 2017

2

1 reference

Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1.

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Transforming growth factor-beta isoform expression in human ovarian tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

TGF-beta inhibits proliferation of and promotes differentiation of human promonocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

A novel protein distinguishes between quiescent and activated forms of the type I transforming growth factor beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

TGF-B2 and soluble p55 TNFR modulate VCAM-1 expression in glioma cells and brain derived endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Microsatellite alterations in plasma DNA of small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Mechanism of TGFbeta receptor inhibition by FKBP12

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Frequent aberration of the transforming growth factor-beta receptor II gene in cell lines but no apparent mutation in pre-invasive and invasive carcinomas of the uterine cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Differential response of cervical intraepithelial and cervical carcinoma cell lines to transforming growth factor-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

HPV16 E6 oncoprotein stimulates the transforming growth factor-beta 1 promoter in fibroblasts through a specific GC-rich sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Decreased expression of transforming growth factor beta receptors on head and neck squamous cell carcinoma tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Microsatellite instability in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Microsatellite instability in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Frameshift mutations in TGFbetaRII, IGFIIR, BAX, hMSH3 and hMSH6 are absent in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Analyses of mutation and loss of heterozygosity of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Effects of type beta transforming growth factor in combination with retinoic acid or tumor necrosis factor on proliferation of a human glioblastoma cell line and clonogenic cells from freshly resected human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Mutations in the SMAD4/DPC4 gene in juvenile polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Analysis of the Smad2 gene in hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

IGFBP-3 mediates TGF beta 1 proliferative response in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Cytokine expression of transforming growth factor-beta2 and interleukin-10 in squamous cell carcinomas of the head and neck. Comparison of tissue expression and serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Processing of the transforming growth factor beta type I and II receptors. Biosynthesis and ligand-induced regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Serum transforming growth factor-beta 1 is related to the degree of immunoparesis in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

A proliferative effect of transforming growth factor-beta1 on a human prostate cancer cell line, TSU-Pr1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Expression and mutational analysis of the MADR2/Smad2 gene in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Defective angiogenesis in mice lacking endoglin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Ubiquitin-dependent degradation of TGF-beta-activated smad2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

HNPCC associated with germline mutation in the TGF-beta type II receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Transcriptional control by the TGF-beta/Smad signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

The prognostic significance of transforming growth factors in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Cloning of a cDNA encoding the human transforming growth factor-beta type II receptor: heterogeneity of the mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Microsatellite instability and loss of heterozygosity in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Down-regulated expression of transforming growth factor beta 1 mRNA in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Mammary tumor suppression by transforming growth factor beta 1 transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Microsatellite instability in human non-melanoma and melanoma skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Chemical hepatocarcinogenesis in transgenic mice overexpressing mature TGF beta-1 in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

DPC4/SMAD4 gene alterations in human cancer, and their functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Gastro-intestinal tumorigenesis in Smad4 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Does mutation of transforming growth factor-beta type II receptor gene play an important role in colorectal polyps?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic human gastrointestinal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Transforming growth factor-beta1 and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

A Smad transcriptional corepressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Elevated serum transforming growth factor beta1 levels in Epstein-Barr virus-associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Disrupted transforming growth factor-beta signaling and deregulated growth in human biliary tract cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Regulation of Smad signalling by protein associations and signalling crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Mutations in a 10-bp polyadenine repeat of transforming growth factor β-receptor type II gene is an infrequent event in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

Microsatellite instability and mutations of p53 and TGF-beta RII genes in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-4652%28200002%29186%3A2%3C153%3A%3AAID-JCP1016%3E3.0.CO%3B2-J

10.1002/1097-4652(200002)186:2<153::AID-JCP1016>3.0.CO;2-J

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11169452